ABTB1 Inhibitors
ABTB1 inhibitors encompass a variety of chemical compounds that indirectly suppress the functional activity of ABTB1 through distinct biochemical pathways and feedback mechanisms. Trichostatin A, a histone deacetylase inhibitor, and 5-Azacytidine, a DNA methyltransferase inhibitor, both modulate chromatin structure, resulting in enhanced transcription and overexpression of ABTB1, which can lead to the protein's functional inhibition via negative feedback. Similarly, proteasome inhibition by MG132 could prevent ABTB1 degradation, leading to an increase in its intracellular levels and subsequent feedback inhibition. LY294002 and Rapamycin, inhibitors of PI3K and mTOR pathways respectively, may disrupt key cell survival and growth pathways, leading to compensatory upregulation of ABTB1 and its functional inhibition. Additionally, PD98059 and U0126, both acting as MEK inhibitors, along with SB203580 and SP600125 targeting p38 MAPK and JNK pathways respectively, could lead to the enhancement of ABTB1 levels through complex feedback loops, contributing to the inhibition of its activity.
Furthermore, Brefeldin A's interference with protein transport can cause cytosolic retention of ABTB1, thus indirectly inhibiting its activity. Cyclosporin A, by inhibiting calcineurin, prevents dephosphorylation of various proteins, leading to increased expression of ABTB1 and its consequent inhibition. The RAF inhibitor ZM 336372 could also invoke feedback mechanisms within the MAPK pathway, resulting in the enhancement of ABTB1 expression and indirect functional inhibition. These chemical compounds, through their targeted action on various signaling molecules and pathways, collectively contribute to the inhibition of ABTB1 by enhancing its expression and triggering feedback mechanisms that modulate its functional activity.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
Histone deacetylase inhibitor which leads to chromatin remodeling. This enhances the transcription of genes including ABTB1, potentially increasing the levels of ABTB1 protein to inhibit its functional activity through negative feedback mechanisms. | ||||||
MG-132 [Z-Leu- Leu-Leu-CHO] | 133407-82-6 | sc-201270 sc-201270A sc-201270B | 5 mg 25 mg 100 mg | $60.00 $265.00 $1000.00 | 163 | |
Proteasome inhibitor that can prevent the degradation of ubiquitinated proteins, which may include ABTB1 if it is regulated by ubiquitination, thus indirectly leading to an increase in ABTB1 levels and subsequent feedback inhibition. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
PI3K inhibitor that can elevate the levels of certain proteins via feedback loops by disrupting PI3K/AKT signaling, potentially enhancing the expression of ABTB1 and leading to its functional inhibition. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
mTOR inhibitor that can upregulate the transcription of various genes due to feedback mechanisms when mTORC1 is inhibited, possibly enhancing ABTB1 expression and inhibiting its activity. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
MEK inhibitor that could lead to the upregulation of ABTB1 through compensatory mechanisms within the MAPK pathway, potentially resulting in the inhibition of ABTB1's function. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
p38 MAPK inhibitor which may enhance the levels of proteins involved in stress responses, including ABTB1, leading to its functional inhibition through feedback inhibition. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
JNK inhibitor that potentially increases ABTB1 expression by alleviating JNK-mediated inhibition of transcription factors that regulate ABTB1, thus indirectly inhibiting ABTB1's activity. | ||||||
Brefeldin A | 20350-15-6 | sc-200861C sc-200861 sc-200861A sc-200861B | 1 mg 5 mg 25 mg 100 mg | $31.00 $53.00 $124.00 $374.00 | 25 | |
Inhibitor of ADP-ribosylation factor which disrupts protein transport within cells. This could lead to an accumulation of ABTB1 in the cytosol, thereby indirectly inhibiting its functional activity. | ||||||
Cyclosporin A | 59865-13-3 | sc-3503 sc-3503-CW sc-3503A sc-3503B sc-3503C sc-3503D | 100 mg 100 mg 500 mg 10 g 25 g 100 g | $63.00 $92.00 $250.00 $485.00 $1035.00 $2141.00 | 69 | |
Calcineurin inhibitor that can upregulate numerous proteins by preventing dephosphorylation, potentially increasing the expression of ABTB1, leading to its functional inhibition. | ||||||
ZM 336372 | 208260-29-1 | sc-202857 | 1 mg | $47.00 | 2 | |
RAF inhibitor which could potentially elevate ABTB1 levels through indirect feedback loops within the MAPK pathway, leading to the inhibition of ABTB1 activity. | ||||||